Theyre still classified as diabetes and weight-loss medications, so doctors dont prescribe them off-label for substance use disorders
USA 109 , 42394244 (2012)
Published in the journal eClinicalMedicine , the findings suggest that GLP-1RAs could be a useful addition for treating binge-eating symptoms
Studies of this kind must be regarded as tentative, however, as there were not adequate controls in the study including a lack of randomization, double-blinding, or placebo
Nevertheless, recent advances in understanding the molecular mechanisms, regulatory factors of GLP-1 secretion, signaling pathways, and transcription factors that are effective in endocrine cell differentiation may pave the way for the development of effective applicable medications that can increase GLP-1 secretion and improve L-cell differentiation
Side effects tend to resolve very quickly once the infusion is slowed down